Butterfly Network, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Butterfly Network, Inc. on August 11, 2026, covering events occurring on August 5, 2026. The Company is a Delaware corporation with its principal executive offices in Burlington, MA, and its Class A common stock trades on the New York Stock Exchange under the symbol BFLY.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of Dr. Erica Schwartz from the Board of Directors. Her resignation became effective on August 5, 2026, immediately following her confirmation by the U.S. Senate as Director of the Centers for Disease Control and Prevention. The Company explicitly states that this resignation is not the result of any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No new risks, contingencies, or unusual items were disclosed in this report.
Key Facts for Investor Verification
- Dr. Erica Schwartz resigned as a director effective August 5, 2026, due to her appointment as CDC Director.
- The resignation was pre-disclosed in a May 8, 2026, Form 8-K and was not caused by any dispute with the Company.
- This filing does not include any financial results or updates to the Company's business strategy.